Mark R. Player
35Patents
6h-index
63Co-inventors
72Inventor score
Filing activity: Nov 3, 1997 → Oct 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6214805A | RNase L activators and antisense oligonucleotides effective to treat RSV infections | Chemistry; Metallurgy | 69 | Expired |
| US7608622B2 | Imidazo[4,5-b]pyrazinone inhibitors of protein kinases | Human Necessities | 50 | Active |
| US7429603B2 | C-fms kinase inhibitors | Chemistry; Metallurgy | 20 | Expired |
| US7790724B2 | c-fms kinase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US7427683B2 | c-fms kinase inhibitors | Chemistry; Metallurgy | 17 | Expired |
| US7321041B2 | 1,6 Naphthyridines useful as inhibitors of SYK kinase | Human Necessities | 13 | Expired |
| US9193736B2 | PDE 10a inhibitors for the treatment of type II diabetes | Human Necessities | 6 | Active |
| US7951829B2 | Benzimidazole modulators of VR1 | Chemistry; Metallurgy | 6 | Active |
| US9067898B1 | Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 6 | Active |
| US7326788B2 | Quinolinone derivatives as inhibitors of c-fms kinase | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7829584B2 | Pyridines and pyridine N-oxides as modulators of thrombin | Chemistry; Metallurgy | 4 | Active |
| US7678911B2 | 1,6 naphthyridines useful as inhibitors of SYK kinase | Human Necessities | 3 | Active |
| US7705151B2 | 1,6 Naphthridines useful as inhibitors of SYK kinase | Human Necessities | 3 | Active |
| US7262210B2 | Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls | Chemistry; Metallurgy | 3 | Expired |
| US9856245B2 | GPR40 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 2 | Active |
| US9908873B2 | GPR40 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 2 | Active |
| US9920040B2 | GPR40 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 2 | Active |
| US8796256B2 | Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators | Human Necessities | 1 | Active |
| US8680098B2 | Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US8217060B2 | Benzimidazole derivatives useful as TRP M8 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US10988433B2 | Cyclohexyl GPR40 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 0 | Active |
| US7642270B2 | 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase | Chemistry; Metallurgy | 0 | Active |
| US10106553B2 | Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes | Chemistry; Metallurgy | 0 | Active |
| US9718820B2 | Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US7728003B2 | 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.